NCT04430036 2024-04-04AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder CancerThe University of Texas Health Science Center at San AntonioPhase 2 Terminated4 enrolled 9 charts